Double Blow For Retail Pharmacists

BMI View: While emerging pharmaceutical markets are a fantastic growth story, the use of higher prices for drugs in emerging markets to offset the austerity of Europe and US healthcare reform is only going to work for so long. Eventually, price reductions will follow from the developed world to countries with high prices, especially those where the state pays for a large proportion of healthcare. In the UAE, price reductions and the removal of discounts means a double blow for pharmacists and distributors. Private independent pharmacies will struggle to deal with the new pricing structure but this presents opportunities for

To read the full article, please choose one of the following options: